Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

56
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
56
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

529
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
529
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

507
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
507
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

81
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
81
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

36
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amplification-Free Detection of Highly Structured RNA Molecules Using SCas12aV2.

Bio-protocol·2026
Same author

Activatable fluorescent probe for auxiliary diagnosis of atherosclerosis: from foam cells to clinical samples.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

From urinalysis to photoacoustic imaging: A versatile probe for malondialdehyde in atherosclerosis.

Bioorganic chemistry·2026
Same author

Stereoselective Ring-Opening Polymerization of Racemic Dithiolactones Assisted by Non-Classical C─H⋯X Interactions.

Angewandte Chemie (International ed. in English)·2026
Same author

USP5 in cancer: a therapeutic window into metabolism and drug resistance.

Journal of translational medicine·2026
Same author

Integrative Analysis of Targeted Genomic Profiling and Immune Cell Infiltration in the Prognosis of Lung Adenocarcinoma.

Journal of visualized experiments : JoVE·2026

Related Experiment Video

Updated: Sep 23, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.0K

Serum urate and heart failure: a bidirectional Mendelian randomization study.

Fangkun Yang1,2,3, Teng Hu4, Hanbin Cui3

  • 1Department of Cardiology, Ningbo Hospital of Zhejiang University (Ningbo First Hospital), School of Medicine, Zhejiang University, Ningbo, China.

European Journal of Preventive Cardiology
|May 17, 2022
PubMed
Summary

High serum urate levels causally increase heart failure (HF) risk. This Mendelian randomization study found genetically predicted urate levels are linked to HF, suggesting urate-lowering therapies may prevent heart failure.

Keywords:
Causal associationGeneticHeart failureMendelian randomizationSerum urate

More Related Videos

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction
07:36

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction

Published on: August 27, 2020

6.3K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Related Experiment Videos

Last Updated: Sep 23, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.0K
Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction
07:36

Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction

Published on: August 27, 2020

6.3K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K

Area of Science:

  • Cardiovascular Science
  • Genetics
  • Metabolic Disease

Background:

  • Observational studies suggest a link between serum urate levels and heart failure (HF).
  • The causal nature of this association is debated due to potential confounding and reverse causality.
  • Genetic prediction offers a method to investigate causality.

Purpose of the Study:

  • To evaluate the causal relationship between genetically predicted serum urate levels and heart failure (HF).
  • To investigate the potential reverse causality of HF on serum urate levels.

Main Methods:

  • A bidirectional Mendelian randomization (MR) study was conducted.
  • Instrumental variables were derived from large genome-wide association studies for serum urate and HF.
  • Summary statistics from HERMES, FinnGen, and UK Biobank were utilized.

Main Results:

  • Genetically predicted serum urate levels showed a significant association with HF (OR, 1.07; 95% CI, 1.03-1.10; P = 8.6×10-5).
  • Sensitivity analyses confirmed the robustness of the main findings.
  • No consistent evidence for a causal effect of HF on serum urate levels was found.

Conclusions:

  • This study provides evidence for a causal effect of genetically predicted serum urate levels on HF.
  • The reverse effect of HF on serum urate levels was not supported.
  • Urate-lowering therapies may offer cardiovascular benefits in HF prevention.